Kingworld Medicines Group Limited (HKG:1110)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.500
0.00 (0.00%)
Mar 10, 2026, 3:41 PM HKT
21.95%
Market Cap 294.80M
Revenue (ttm) 1.03B
Net Income (ttm) 5.95M
Shares Out 589.60M
EPS (ttm) 0.01
PE Ratio 47.72
Forward PE n/a
Dividend 0.03 (6.34%)
Ex-Dividend Date Jun 5, 2025
Volume 752,000
Average Volume 834,400
Open 0.500
Previous Close 0.500
Day's Range 0.495 - 0.500
52-Week Range 0.383 - 0.650
Beta 0.99
RSI 36.24
Earnings Date Mar 27, 2026

About Kingworld Medicines Group

Kingworld Medicines Group Limited, an investment holding company, primarily engages in the distribution and sale of branded imported pharmaceutical and healthcare products. The company offers products for relieving cough, alleviating phlegm, soothing asthma, enhancing respiratory system, aiding digestion, promoting intestinal health, activating blood circulation, relieving pain, combating flu, and other categories under the Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, Kingworld Imada Red Flower Oil, Culturelle probiotics product series brands... [Read more]

Sector Healthcare
Founded 1996
Employees 759
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1110
Full Company Profile

Financial Performance

In 2024, Kingworld Medicines Group's revenue was 1.06 billion, a decrease of -1.63% compared to the previous year's 1.08 billion. Earnings were 41.56 million, an increase of 9.08%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.